MR-proADM as prognostic factor of outcome in COVID-19 patients
COVID-19 환자에서 예후 인자로서의 MR-proADM
Article
[키워드] Admission
affected
Analysis
assist
association
AUROC
avoidance
Bacteria
Biomarker
clinical
clinical assessment
clinical phenotype
collected
Complete
COVID-19 patient
COVID-19 patients
cytokine
Cytokines
data set
death
demographic
develop
disease severity
Escalation
fungi
Hospital admission
IL-1B
IL-6
IL-8
Inclusion
Infectious diseases
Inflammatory cytokines
intubation
Italy
MR-proADM
Multivariate analysis
neutrophil
neutrophil count
Odds ratio
Organ failure
orotracheal intubation
outcome
Pathogenesis
Patient
Pneumonia
Pragmatic
Prognosis
Prognostic factor
Regional
Retrospective analysis
SARS-CoV-2
SARS-CoV-2 pneumonia
scoring system
sensitivity
Sepsis
Septic shock
severe disease
severity of COVID-19
significantly
SOFA score
specificity
Therapies
TNF-α
Triaging
trials
university
viruses
was performed
were measured
WHO
[DOI] 10.1038/s41598-021-84478-1 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41598-021-84478-1 PMC 바로가기 [Article Type] Article